BICYCLE THERAPEUTICS PLC (BCYC) — Institutional Holders, Q2 2026 (page 2)
104 institutional investment managers reported a BCYC position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $158.0M. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 101 to 104. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
BCYC 13F holders ranked 101–104 of 104
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 101 | OSAIC#101 · 10 sh | 10 | $42.00 | 0.00% | 0.0% |
| 102 | FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A.#102 · 9 sh | 9 | $38.00 | — | 0.0% |
| 103 | SBI Securities , Ltd.#103 · 6 sh | 6 | $25.00 | — | 0.0% |
| 104 | Caitlin John#104 · 2 sh | 2 | $8.00 | 0.00% | 0.0% |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.